marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 10-31-2024
Regeneron Pharmaceuticals Cash Flow 2011-2024 | REGN
Annual Cash Flow Regeneron Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
4.59 B | 5.01 B | 7.08 B | 2.62 B | 2.43 B | 2.2 B | 1.31 B | 1.49 B | 1.33 B | 752 M | 589 M | -74.6 M | -142 M |
Depreciation & Amortization |
421 M | 341 M | 286 M | 236 M | 210 M | 148 M | 146 M | 105 M | 74.9 M | 52.7 M | 41.2 M | 36.9 M | 31.1 M |
Accounts Payables |
607 M | 589 M | 564 M | 476 M | 418 M | 218 M | - | 135 M | 141 M | 99.5 M | 61.9 M | 38.9 M | 27.7 M |
Accounts Receivables |
5.67 B | 5.33 B | 6.04 B | 3.11 B | 2.1 B | 1.72 B | 1.54 B | 1.34 B | 1.15 B | 739 M | 787 M | 593 M | 28.3 M |
Total Inventories |
2.58 B | 2.4 B | 1.95 B | 1.92 B | 1.42 B | 1.15 B | 726 M | 399 M | 239 M | 129 M | 70.4 M | 28.6 M | - |
All numbers in USD currency
Quarterly Cash Flow Regeneron Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | 1.51 B | - | - | 1.37 B | - | 3.3 B | - | 2.1 B | - | 4.71 B | - | 668 M | - | 1.39 B | 1.64 B | 698 M | - | 1.64 B | 1.09 B | 897 M | - | 1.47 B | 1.01 B | 619 M | - | 740 M | 325 M | 356 M | - | 1.1 B | 444 M | 45 M | - | 1.05 B | 156 M | -102 M | - | 554 M | 390 M | 53.5 M | - | 307 M | 214 M | 86.2 M | - | -168 M | -165 M | -87 M | - | -91.4 M | -44.6 M | -10.6 M |
Depreciation & Amortization |
- | - | 114 M | - | - | 99.5 M | - | 241 M | - | 74.3 M | - | 212 M | - | 67.4 M | - | 174 M | 115 M | 56.1 M | - | 156 M | 103 M | 51 M | - | 105 M | 70 M | 36.4 M | - | 111 M | 73.2 M | 38.1 M | - | 75.8 M | 48 M | 23 M | - | 52 M | 31.3 M | 16 M | - | 38.6 M | 24.5 M | 11.5 M | - | 29.9 M | 19.1 M | 9.41 M | - | 27.2 M | 17.8 M | 8.42 M | - | 23.2 M | 14.9 M | 6.98 M |
Accounts Payables |
497 M | 562 M | 671 M | 537 M | 547 M | 600 M | 589 M | - | - | - | 564 M | - | - | - | 476 M | - | - | - | 418 M | - | - | - | 218 M | - | - | - | 178 M | 154 M | 151 M | 142 M | 135 M | 135 M | 135 M | 135 M | 141 M | 141 M | 141 M | 141 M | 99.5 M | 99.5 M | 99.5 M | 99.5 M | 61.9 M | 61.9 M | 61.9 M | 61.9 M | 38.9 M | 38.9 M | 38.9 M | 38.9 M | 27.7 M | 27.7 M | 27.7 M | 27.7 M |
Accounts Receivables |
6.11 B | 5.72 B | 5.22 B | 5.58 B | 5.12 B | 5.12 B | 5.33 B | 5.55 B | - | 4.84 B | 6.04 B | 5.45 B | 7 B | 4.17 B | 4.11 B | 4.11 B | 4.11 B | 4.11 B | 2.1 B | 2.1 B | 2.1 B | 2.1 B | 1.72 B | 1.72 B | 1.72 B | 1.72 B | 1.54 B | 1.54 B | 1.54 B | 1.54 B | 1.34 B | 1.34 B | 1.34 B | 1.34 B | 1.15 B | 1.15 B | 1.15 B | 1.15 B | 739 M | 739 M | 739 M | 739 M | 787 M | 787 M | 787 M | 787 M | 593 M | 593 M | 593 M | 593 M | 28.3 M | 28.3 M | 28.3 M | 28.3 M |
Total Inventories |
3.02 B | 2.87 B | 2.71 B | 2.56 B | 2.51 B | 2.42 B | 2.4 B | 2.41 B | - | 1.99 B | 1.95 B | 2.05 B | 1.98 B | 2.16 B | 1.92 B | 1.92 B | 1.92 B | 1.92 B | 1.42 B | 1.42 B | 1.42 B | 1.42 B | 1.15 B | 1.15 B | 1.15 B | 1.15 B | 726 M | 726 M | 726 M | 726 M | 399 M | 399 M | 399 M | 399 M | 239 M | 239 M | 239 M | 239 M | 129 M | 129 M | 129 M | 129 M | 70.4 M | 70.4 M | 70.4 M | 70.4 M | 28.6 M | 28.6 M | 28.6 M | 28.6 M | 16.6 M | 16.6 M | 3.7 M | 3.5 M |
All numbers in USD currency